{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:23:06Z","timestamp":1793740986073,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"DOI":"10.1038\/emm.2016.159","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T08:01:31Z","timestamp":1488528091000},"page":"e298-e298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"49","author":[{"given":"Young C","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Y","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0299-1613","authenticated-orcid":false,"given":"Sang R","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk W","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Bok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Ho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Yoon","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung K","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"key":"BFemm2016159_CR1","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt JM, Dawson VL, Dawson TM . Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 2006; 116: 1744\u20131754.","journal-title":"J Clin Invest"},{"key":"BFemm2016159_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S . Parkinson's disease: mechanisms and models. Neuron 2003; 39: 889\u2013909.","journal-title":"Neuron"},{"key":"BFemm2016159_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5483\/BMBRep.2010.43.4.233","volume":"43","author":"W Seol","year":"2010","unstructured":"Seol W . Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease. BMB Rep 2010; 43: 233\u2013244.","journal-title":"BMB Rep"},{"key":"BFemm2016159_CR4","doi-asserted-by":"publisher","first-page":"6594","DOI":"10.1523\/JNEUROSCI.0970-05.2005","volume":"25","author":"DK Choi","year":"2005","unstructured":"Choi DK, Pennathur S, Perier C, Tieu K, Teismann P, Wu DC et al. Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson\u2019s disease in mice. J Neurosci 2005; 25: 6594\u20136600.","journal-title":"J Neurosci"},{"key":"BFemm2016159_CR5","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1096\/fj.03-0109fje","volume":"17","author":"HM Gao","year":"2003","unstructured":"Gao HM, Liu B, Zhang W, Hong JS . Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J 2003; 17: 1954\u20131956.","journal-title":"FASEB J"},{"key":"BFemm2016159_CR6","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1073\/pnas.0937239100","volume":"100","author":"DC Wu","year":"2003","unstructured":"Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H et al. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci USA 2003; 100: 6145\u20136150.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2016159_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5483\/BMBRep.2010.43.4.225","volume":"43","author":"YC Chung","year":"2010","unstructured":"Chung YC, Ko HW, Bok E, Park ES, Huh SH, Nam JH et al. The role of neuroinflammation on the pathogenesis of Parkinson's disease. BMB Rep 2010; 43: 225\u2013232.","journal-title":"BMB Rep"},{"key":"BFemm2016159_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"GT Liberatore","year":"1999","unstructured":"Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 1999; 5: 1403\u20131409.","journal-title":"Nat Med"},{"key":"BFemm2016159_CR9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 2002; 22: 1763\u20131771.","journal-title":"J Neurosci"},{"key":"BFemm2016159_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/138161208783330754","volume":"14","author":"MJ Gunthorpe","year":"2008","unstructured":"Gunthorpe MJ, Szallasi A . Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms. Curr Pharml Des 2008; 14: 32\u201341.","journal-title":"Curr Pharml Des"},{"key":"BFemm2016159_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/138161208783330790","volume":"14","author":"K Starowicz","year":"2008","unstructured":"Starowicz K, Cristino L, Di Marzo V . TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications. Curr Pharm Des 2008; 14: 42\u201354.","journal-title":"Curr Pharm Des"},{"key":"BFemm2016159_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.tins.2008.12.006","volume":"32","author":"JA Kauer","year":"2009","unstructured":"Kauer JA, Gibson HE . Hot flash: TRPV channels in the brain. Trends Neurosci 2009; 32: 215\u2013224.","journal-title":"Trends Neurosci"},{"key":"BFemm2016159_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.expneurol.2007.07.021","volume":"208","author":"MG Morgese","year":"2007","unstructured":"Morgese MG, Cassano T, Cuomo V, Giuffrida A . Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. Exp Neurol 2007; 208: 110\u2013119.","journal-title":"Exp Neurol"},{"key":"BFemm2016159_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.nbd.2013.10.008","volume":"62","author":"R Gonzalez-Aparicio","year":"2014","unstructured":"Gonzalez-Aparicio R, Moratalla R . Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson s disease. Neurobiol Dis 2014; 62: 416\u2013425.","journal-title":"Neurobiol Dis"},{"key":"BFemm2016159_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainresbull.2012.07.001","volume":"89","author":"ES Park","year":"2012","unstructured":"Park ES, Kim SR, Jin BK . Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress. Brain Res Bull 2012; 89: 92\u201396.","journal-title":"Brain Res Bull"},{"key":"BFemm2016159_CR16","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1523\/JNEUROSCI.23-08-03136.2003","volume":"23","author":"S Marinelli","year":"2003","unstructured":"Marinelli S, Di Marzo V, Berretta N, Matias I, Maccarrone M, Bernardi G et al. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci 2003; 23: 3136\u20133144.","journal-title":"J Neurosci"},{"key":"BFemm2016159_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2004.02.016","volume":"1007","author":"E de Lago","year":"2004","unstructured":"de Lago E, de Miguel R, Lastres-Becker I, Ramos JA, Fernandez-Ruiz J . Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. Brain Res 2004; 1007: 152\u2013159.","journal-title":"Brain Res"},{"key":"BFemm2016159_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0014-2999(01)01012-3","volume":"420","author":"V Di Marzo","year":"2001","unstructured":"Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB et al. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur J Pharmacol 2001; 420: 123\u2013131.","journal-title":"Eur J Pharmacol"},{"key":"BFemm2016159_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.neuropharm.2006.04.016","volume":"51","author":"J Lee","year":"2006","unstructured":"Lee J, Di Marzo V, Brotchie JM . A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats. Neuropharmacology 2006; 51: 557\u2013565.","journal-title":"Neuropharmacology"},{"key":"BFemm2016159_CR20","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.4049\/jimmunol.1102435","volume":"187","author":"YC Chung","year":"2011","unstructured":"Chung YC, Bok E, Huh SH, Park JY, Yoon SH, Kim SR et al. Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation. J Immunol 2011; 187: 6508\u20136517.","journal-title":"J Immunol"},{"key":"BFemm2016159_CR21","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.4049\/jimmunol.1000208","volume":"185","author":"YC Chung","year":"2010","unstructured":"Chung YC, Kim SR, Jin BK . Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease. J Immunol 2010; 185: 1230\u20131237.","journal-title":"J Immunol"},{"key":"BFemm2016159_CR22","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4049\/jimmunol.1100009","volume":"187","author":"SH Huh","year":"2011","unstructured":"Huh SH, Chung YC, Piao Y, Jin MY, Son HJ, Yoon NS et al. Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson's disease. J Immunol 2011; 187: 960\u2013969.","journal-title":"J Immunol"},{"key":"BFemm2016159_CR23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0022-3565(25)24767-X","volume":"257","author":"A Giovanni","year":"1991","unstructured":"Giovanni A, Sieber BA, Heikkila RE, Sonsalla PK . Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice. J Pharmacol Exp Ther 1991; 257: 691\u2013697.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFemm2016159_CR24","first-page":"135","volume":"16","author":"S Przedborski","year":"2000","unstructured":"Przedborski S, Jackson-Lewis V, Djaldetti R, Liberatore G, Vila M, Vukosavic S et al. The parkinsonian toxin MPTP: action and mechanism. Restor Neurol Neurosci 2000; 16: 135\u2013142.","journal-title":"Restor Neurol Neurosci"},{"key":"BFemm2016159_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS . Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8: 57\u201369.","journal-title":"Nat Rev Neurosci"},{"key":"BFemm2016159_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.mcn.2005.10.016","volume":"31","author":"JS Henkel","year":"2006","unstructured":"Henkel JS, Beers DR, Siklos L, Appel SH . The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci 2006; 31: 427\u2013437.","journal-title":"Mol Cell Neurosci"},{"key":"BFemm2016159_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0887-2333(02)00028-0","volume":"16","author":"S Travaglione","year":"2002","unstructured":"Travaglione S, Falzano L, Fabbri A, Stringaro A, Fais S, Fiorentini C . Epithelial cells and expression of the phagocytic marker CD68: scavenging of apoptotic bodies following Rho activation. Toxicol In Vitro 2002; 16: 405\u2013411.","journal-title":"Toxicol In Vitro"},{"key":"BFemm2016159_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.neuropharm.2011.01.043","volume":"60","author":"YC Chung","year":"2011","unstructured":"Chung YC, Kim SR, Park JY, Chung ES, Park KW, Won SY et al. Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology 2011; 60: 963\u2013974.","journal-title":"Neuropharmacology"},{"key":"BFemm2016159_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1471-4159.2002.01131.x","volume":"83","author":"LM Bolin","year":"2002","unstructured":"Bolin LM, Strycharska-Orczyk I, Murray R, Langston JW, Di Monte D . Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. J Neurochem 2002; 83: 167\u2013175.","journal-title":"J Neurochem"},{"key":"BFemm2016159_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10571-007-9241-2","volume":"28","author":"C Oki","year":"2008","unstructured":"Oki C, Watanabe Y, Yokoyama H, Shimoda T, Kato H, Araki T . Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice. Cell Mol Neurobiol 2008; 28: 417\u2013430.","journal-title":"Cell Mol Neurobiol"},{"key":"BFemm2016159_CR31","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/j.1471-4159.2005.03503.x","volume":"95","author":"SH Choi","year":"2005","unstructured":"Choi SH, Lee DY, Chung ES, Hong YB, Kim SU, Jin BK . Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem 2005; 95: 1755\u20131765.","journal-title":"J Neurochem"},{"key":"BFemm2016159_CR32","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1523\/JNEUROSCI.4306-04.2005","volume":"25","author":"SH Choi","year":"2005","unstructured":"Choi SH, Lee DY, Kim SU, Jin BK . Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J Neurosci 2005; 25: 4082\u20134090.","journal-title":"J Neurosci"},{"key":"BFemm2016159_CR33","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG . Glial reactions in Parkinson's disease. Mov Disord 2008; 23: 474\u2013483.","journal-title":"Mov Disord"},{"key":"BFemm2016159_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0306-4522(99)00455-8","volume":"95","author":"B Mirza","year":"2000","unstructured":"Mirza B, Hadberg H, Thomsen P, Moos T . The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 2000; 95: 425\u2013432.","journal-title":"Neuroscience"},{"key":"BFemm2016159_CR35","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.exger.2007.04.010","volume":"42","author":"A Vroon","year":"2007","unstructured":"Vroon A, Drukarch B, Bol JG, Cras P, Breve JJ, Allan SM et al. Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb. Exp Gerontol 2007; 42: 762\u2013771.","journal-title":"Exp Gerontol"},{"key":"BFemm2016159_CR36","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V93.5.1464","volume":"93","author":"BM Babior","year":"1999","unstructured":"Babior BM . NADPH oxidase: an update. Blood 1999; 93: 1464\u20131476.","journal-title":"Blood"},{"key":"BFemm2016159_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbabio.2004.03.008","volume":"1657","author":"AR Cross","year":"2004","unstructured":"Cross AR, Segal AW . The NADPH oxidase of professional phagocytes\u2014prototype of the NOX electron transport chain systems. Biochim Biophys Acta 2004; 1657: 1\u201322.","journal-title":"Biochim Biophys Acta"},{"key":"BFemm2016159_CR38","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.4049\/jimmunol.178.10.6573","volume":"178","author":"J Fan","year":"2007","unstructured":"Fan J, Li Y, Levy RM, Fan JJ, Hackam DJ, Vodovotz Y et al. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol 2007; 178: 6573\u20136580.","journal-title":"J Immunol"},{"key":"BFemm2016159_CR39","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/jnr.21191","volume":"85","author":"Y Nakabeppu","year":"2007","unstructured":"Nakabeppu Y, Tsuchimoto D, Yamaguchi H, Sakumi K . Oxidative damage in nucleic acids and Parkinson's disease. J Neurosci Res 2007; 85: 919\u2013934.","journal-title":"J Neurosci Res"},{"key":"BFemm2016159_CR40","first-page":"143","volume":"58","author":"T Nagatsu","year":"2000","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A . Cytokines in Parkinson's disease. J Neural Transm Suppl 2000; 58: 143\u2013151.","journal-title":"J Neural Transm Suppl"},{"key":"BFemm2016159_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ejphar.2009.10.044","volume":"627","author":"F Tsuji","year":"2010","unstructured":"Tsuji F, Murai M, Oki K, Seki I, Ueda K, Inoue H et al. Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents. Eur J Pharmacol 2010; 627: 332\u2013339.","journal-title":"Eur J Pharmacol"},{"key":"BFemm2016159_CR42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1124\/jpet.108.146241","volume":"329","author":"K Ueda","year":"2009","unstructured":"Ueda K, Tsuji F, Hirata T, Murai M, Aono H, Takaoka M et al. Preventive effect of SA13353 [1-[2-(1-adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea], a novel transient receptor potential vanilloid 1 agonist, on ischemia\/reperfusion-induced renal injury in rats. J Pharmacol Exp Ther 2009; 329: 202\u2013209.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFemm2016159_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1073\/pnas.0405193102","volume":"102","author":"D Lau","year":"2005","unstructured":"Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM et al. Myeloperoxidase mediates neutrophil activation by association with CD11b\/CD18 integrins. Proc Natl Acad Sci USA 2005; 102: 431\u2013436.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Experimental & Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/emm2016159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm2016159","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm2016159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T23:43:42Z","timestamp":1750031022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/emm2016159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"alternative-id":["BFemm2016159"],"URL":"https:\/\/doi.org\/10.1038\/emm.2016.159","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,3]]},"assertion":[{"value":"1 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}